Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of First-Line Bosutinib versus Imatinib in the BFORE trial : 18-Month Follow-up
Efficacy and Safety of First-Line Bosutinib versus Imatinib in the BFORE trial : 18-Month Follow-up
2018
Richard E. Clark
J. E. Cortes
Michael J. Mauro
P. le Coutre
Tim H. Brümmendorf
Irina Dyagil
Rocco J. Crescenzo
Nathalie Bardy-Bouxin
Charles Chuah
Eric Leip
Valentín García Gutiérrez
A. Hochhaus
D. W. Kim
Nataliia Glushko
Mochael W. Deininger
Dragana Milojkovic
Carlo Gambacorti-Passerini
Keywords:
Cancer research
Imatinib
Bosutinib
Medicine
first line
month follow up
Oncology
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]